Bellevue Competitors

Delisted . USA . 
Stock . Bellevue Life Sciences
BLACWDelisted Stock   0.05  0.02  26.43%   
Bellevue Life Sciences competes with Mitsui Chemicals, Net Lease, China Aircraft, Sun Art, and Dupont De; as well as few others. The company classifies itself under Capital Markets sector and is part of Financials industry. Analyzing Bellevue Life competition allows you to expand the diversification possibilities of your existing portfolios and to get a better perspective on locking in new positions. Investors sometimes prefer comparable analysis of Bellevue Life to its intrinsic valuation because they are able to contrast its competitors on a relative basis. Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in services.

Bellevue Life vs Robinsons Retail Correlation

Weak diversification

The correlation between Bellevue Life Sciences and RRETY is 0.36 (i.e., Weak diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Bellevue Life Sciences and RRETY in the same portfolio, assuming nothing else is changed.

Moving against Bellevue Stock

  0.69PBCRY Bank Central AsiaPairCorr
  0.54PBCRF PT Bank CentralPairCorr
Specify up to 10 symbols:
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Bellevue Life's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Hype
Prediction
LowEstimatedHigh
0.050.050.06
Details
Intrinsic
Valuation
LowRealHigh
0.040.040.06
Details
Naive
Forecast
LowNextHigh
0.070.070.07
Details
Bollinger
Band Projection (param)
LowerMiddle BandUpper
-0.340.060.46
Details

Bellevue Life Competition Correlation Matrix

Typically, diversification allows investors to combine positions across different asset classes to reduce overall portfolio risk. Correlation between Bellevue Life and its competitors represents the degree of relationship between the price movements of corresponding delisted stocks. A correlation of about +1.0 implies that the price of Bellevue and its corresponding peer move in tandem. A correlation of -1.0 means that prices move in opposite directions. A correlation of close to zero suggests that the price movements of assets are uncorrelated; in other words, the historical price movement of Bellevue Life Sciences does not affect the price movement of the other competitor.

High positive correlations

CFRLF
+ 0.88
MITUY
DD
+ 0.85
MITUY
DD
+ 0.78
CFRLF
RRETY
+ 0.77
CFRLF
RRETY
+ 0.76
MITUY
CCEC
+ 0.7
DD
  

High negative correlations

NLOP
- 0.73
MITUY
SURRY
- 0.71
CFRLF
DD
- 0.69
SURRY
CFRLF
- 0.66
NLOP
SURRY
- 0.66
MITUY
RRETY
- 0.62
SURRY

Risk-Adjusted Indicators

There is a big difference between Bellevue Stock performing well and Bellevue Life Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Bellevue Life's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.

Bellevue Life Competitive Analysis

The better you understand Bellevue Life competitors, the better chance you have of utilizing it as a position in your portfolios. From an individual investor's perspective, Bellevue Life's competitive analysis can cover a whole range of metrics. Some of these will be more critical depending on who you are as an investor and how you react to market volatility. However, if you are locking your investment sandscape to a long-term horizon, comparing the fundamental indicator across Bellevue Life's competition over several years is one of the best ways to analyze its investment potential.
    
 Better Than Average     
    
 Worse Than Peers    View Performance Chart
BLACW MITUY NLOP CFRLF SURRY DD CCEC RRETY
 26.43 
 0.05 
Bellevue
 9.63 
 14.91 
Mitsui
 4.04 
 13.65 
Net
 0.00 
 0.64 
China
 0.00 
 1.90 
Sun
 0.34 
 50.41 
Dupont
 0.39 
 23.09 
Capital
 0.00 
 5.75 
Robinsons
Market Volatility
(90 Days Market Risk)
Not too volatile
Not too volatile
Very steady
Very risky
Dangerous
Very steady
Very steady
Very steady
Market Performance
(90 Days Performance)
Weakest
Good
Soft
Good
Weakest
Solid
Good
Good
Odds of Financial Distress
(Probability Of Bankruptcy)
Hazard
Low
Moderate
Low
Small
Low
Tiny
Low
Current Valuation
(Equity Enterprise Value)
Over Valued
Under Valued
Under Valued
Over Valued
Over Valued
Under Valued
Fairly Valued
Fairly Valued
Buy or Sell Advice
(Average Analysts Consensus)
Not Available
Not Available
Buy
Not Available
Not Available
Strong Buy
Buy
Not Available
Trade Advice
(90 Days Macroaxis Advice)
Not Rated
Strong Buy
Sell
Strong Sell
Strong Sell
Buy
Strong Sell
Hold
Current Ratio
N/A
1.41 X
N/A
1.58 X
0.99 X
2.39 X
N/A
1.41 X
Net Asset
36.63 M
1.93 T
805.07 M
50.03 B
65.75 B
21.57 B
4.11 B
134.23 B
Profit Margin
N/A
0.04 %
(1.56) %
0.06 %
(0.01) %
(0.11) %
0.56 %
0.04 %
EBITDA
(35.39 K)
229.15 B
53.13 M
2.86 B
17 M
1.16 B
296.46 M
14.32 B
Operating Margin
N/A
0.06 %
0.37 %
0.33 %
0.01 %
0.35 %
0.51 %
0.05 %
Current Valuation
N/A
7.72 B
210.64 M
5.53 B
1.35 B
23.04 B
3.53 B
1.86 B
Price To Book
N/A
0.77 X
0.47 X
0.57 X
0.92 X
1.48 X
0.93 X
1.17 X
Retained Earnings
(3.91 M)
N/A
(234.44 M)
N/A
8.41 B
(24.28 B)
102.61 M
N/A
Current Asset
N/A
N/A
N/A
N/A
18.32 B
17.12 B
N/A
N/A
Five Year Return
N/A
N/A
N/A
N/A
2.22 %
2.50 %
N/A
1.81 %
Beta
N/A
0.86
0.36
0.81
0.75
1.16
0.65
0.59
Number Of Employees
N/A
18.78 K
N/A
165
114.49 K
15 K
N/A
20.54 K
Shares Outstanding
N/A
385.4 M
14.81 M
744.36 M
953.97 M
409.2 M
59.08 M
147.76 M
Cash Flow From Operations
(818.77 K)
92.58 B
71.86 M
2.17 B
3.58 B
1.41 B
240.52 M
7.18 B
Annual Yield
N/A
0.04 %
0.09 %
0.08 %
0.01 %
0.02 %
0.03 %
0.04 %
Total Debt
4.11 M
319.47 B
169.47 M
40.48 B
7.38 B
3.19 B
2.58 B
34.31 B
Return On Equity
N/A
0.1
-0.34
0.0348
-0.0398
0.0052
0.0783
0.0904
Z Score
N/A
N/A
N/A
N/A
1.0
N/A
N/A
1.0
Number Of Shares Shorted
3.31 K
N/A
580.38 K
N/A
N/A
9.24 M
41.71 K
N/A
Return On Asset
N/A
0.034
0.0259
0.0041
0.0055
0.0186
0.0344
0.0422
Book Value Per Share
N/A
1,997 X
29.04 X
6.12 X
24.65 X
34.02 X
24.76 X
478.37 X
Current Liabilities
N/A
N/A
N/A
N/A
29.34 B
8.9 B
N/A
N/A
Total Asset
36.63 M
1.93 T
805.07 M
50.03 B
65.75 B
21.57 B
4.11 B
134.23 B
Debt To Equity
N/A
0.87 %
N/A
6.43 %
0.29 %
0.48 %
N/A
0.46 %
Last Dividend Paid
N/A
120.0
N/A
0.41
0.038
1.43
0.6
2.0
Short Ratio
N/A
N/A
1.80 X
N/A
N/A
1.96 X
9.60 X
N/A
Target Price
N/A
N/A
46.0
N/A
N/A
56.13
25.8
N/A
Shares Owned By Institutions
N/A
N/A
59.14 %
2.10 %
N/A
78.86 %
0.42 %
N/A
Market Capitalization
N/A
4.66 B
202.21 M
517.11 M
3.83 B
21.12 B
1.36 B
1.58 B
Price To Earning
N/A
10.81 X
N/A
10.18 X
4.80 X
21.91 X
N/A
23.98 X
Price To Earnings To Growth
N/A
N/A
N/A
N/A
1.53 X
0.78 X
N/A
N/A
Price To Sales
N/A
0 X
1.74 X
0.29 X
0.04 X
3.08 X
3.23 X
0.01 X
Net Income
403.78 K
109.99 B
(91.39 M)
525.78 M
(739 M)
98 M
53.06 M
4.53 B
Earnings Per Share
N/A
1.55 X
(12.21) X
0.05 X
(0.12) X
0.21 X
1.38 X
0.76 X
Shares Owned By Insiders
N/A
N/A
0.65 %
64.74 %
N/A
0.26 %
86.40 %
N/A
Revenue
N/A
1.61 T
142.25 M
2.5 B
88.13 B
6.85 B
369.41 M
153.33 B
Working Capital
(2.02 M)
N/A
24.28 M
N/A
(11.01 B)
1.56 B
162.05 M
N/A
Cash And Equivalents
N/A
233.63 B
N/A
3.19 B
18.66 B
715 M
N/A
13.15 B
Cash Per Share
N/A
604.18 X
N/A
4.34 X
19.56 X
3.59 X
N/A
88.52 X
Gross Profit
N/A
378.74 B
101.34 M
1.29 B
21.47 B
2.36 B
339.46 M
35.08 B
Day Typical Price
0.0577
14.91
13.51
0.64
1.9
50.38
23.03
5.75
Accumulation Distribution
0.26
N/A
0.0514
N/A
N/A
0.0232
0.043
N/A
Market Facilitation Index
0.0185
N/A
0.71
N/A
N/A
1.18
1.01
N/A
Daily Balance Of Power
(1.00)
9.2 T
0.7465
0.0
0.0
0.1441
0.0891
0.0
Period Momentum Indicator
(0.02)
1.31
0.53
N/A
N/A
0.17
0.09
N/A
Rate Of Daily Change
0.74
1.1
1.04
1.0
1.0
1.0
1.0
1.0
Day Median Price
0.0608
14.91
13.45
0.64
1.9
50.36
22.99
5.75
Price Action Indicator
(0.02)
0.66
0.47
N/A
N/A
0.13
0.14
N/A
Relative Strength Index
53.49
92.02
46.39
100.0
30.88
62.38
56.69
100.0
Coefficient Of Variation
649.1
545.55
6712.85
695.7
(15,730)
475.92
999.55
(1,622)
Mean Deviation
18.62
0.9387
1.03
0.3
1.21
1.33
1.56
0.3599
Jensen Alpha
4.03
0.3947
0.0044
0.1546
(0.02)
0.28
0.1994
(0.13)
Total Risk Alpha
1.62
0.2046
(0.12)
0.0451
(0.44)
0.2063
0.0055
(0.25)
Sortino Ratio
0.1928
N/A
(0.04)
N/A
N/A
0.1654
0.0632
N/A
Downside Variance
430.07
N/A
2.08
N/A
N/A
3.42
3.91
N/A
Standard Deviation
26.48
2.36
1.36
1.08
4.35
1.84
2.05
1.56
Kurtosis
2.02
21.03
1.8
61.57
22.78
1.23
0.0571
53.68
Potential Upside
56.5
N/A
2.11
N/A
3.18
3.82
4.46
N/A
Treynor Ratio
7.69
1.05
0.1219
(1.03)
0.1261
0.2754
(3.58)
(0.28)
Maximum Drawdown
127.93
13.84
7.36
8.62
45.55
10.08
8.78
11.97
Variance
700.94
5.59
1.86
1.16
18.96
3.38
4.22
2.44
Market Risk Adjusted Performance
7.7
1.06
0.1319
(1.02)
0.1361
0.2854
(3.57)
(0.27)
Risk Adjusted Performance
0.1272
0.1465
0.0158
0.1125
0.0034
0.1661
0.0826
(0.04)
Skewness
1.22
4.45
(0.19)
7.76
0.2626
0.2014
0.1911
(6.77)
Semi Deviation
15.51
N/A
1.35
N/A
N/A
1.38
1.74
N/A
Information Ratio
0.151
0.1492
(0.04)
0.0689
(0.02)
0.1663
0.0609
(0.11)
Value At Risk
(35.90)
N/A
(1.78)
N/A
(3.08)
(2.16)
(3.08)
N/A
Expected Short fall
(27.17)
N/A
(1.08)
N/A
N/A
(1.38)
(1.67)
N/A
Downside Deviation
20.74
N/A
1.44
N/A
N/A
1.85
1.98
N/A
Semi Variance
240.49
N/A
1.81
N/A
N/A
1.9
3.01
N/A

Bellevue Life Competition Performance Charts

Five steps to successful analysis of Bellevue Life Competition

Bellevue Life's competitive analysis is the process of researching and evaluating its competitive landscape. It provides an understanding of the strengths, weaknesses, opportunities, and threats (SWOT) faced by Bellevue Life Sciences in relation to its competition. Bellevue Life's competition analysis typically involves several steps, including:
  • Identifying the key players in the market: This involves identifying the major competitors of Bellevue Life in the market, both direct and indirect, as well as new entrants and disruptive technologies.
  • Assessing the strengths and weaknesses of each competitor: This involves evaluating each competitor's strengths and weaknesses in areas such as product offerings, market share, brand recognition, financial performance, and distribution channels.
  • Understanding the competitive environment: This involves evaluating the regulatory environment, economic conditions, and other factors that may impact Bellevue Life's competitive landscape.
  • Identifying opportunities and threats: This involves using the information gathered during the analysis to identify opportunities and threats to Bellevue Life Sciences, and developing a strategy to address them.
  • Evaluating the competitive landscape: This involves understanding the competitive dynamics of the market, such as pricing, marketing, and distribution strategies, as well as analyzing the competitive advantage of each competitor.
Competitive analysis is an essential tool for businesses to stay ahead of the competition and can be used to inform decision-making and strategy development. By understanding the competitive landscape and staying informed about the activities of competitors, a company can make more informed decisions and improve its overall performance.

Complement your Bellevue Life position

In addition to having Bellevue Life in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Driverless Cars Thematic Idea Now

Driverless Cars
Driverless Cars Theme
It encompasses large technology companies, automotive makers, security firms, and thematic ETFs across multiple industries. These entities are directly or indirectly involved in shaping the development and marketing of self-driving vehicles. The Driverless Cars theme has 36 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Driverless Cars Theme or any other thematic opportunities.
View All  Next Launch
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in services.
You can also try the Portfolio Volatility module to check portfolio volatility and analyze historical return density to properly model market risk.

Other Consideration for investing in Bellevue Stock

If you are still planning to invest in Bellevue Life Sciences check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Bellevue Life's history and understand the potential risks before investing.
Risk-Return Analysis
View associations between returns expected from investment and the risk you assume
Crypto Correlations
Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins
Piotroski F Score
Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals
Global Correlations
Find global opportunities by holding instruments from different markets
FinTech Suite
Use AI to screen and filter profitable investment opportunities
Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios
Volatility Analysis
Get historical volatility and risk analysis based on latest market data
Portfolio Dashboard
Portfolio dashboard that provides centralized access to all your investments
Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk
Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions
 
Feedback Blog
Made with optimal in San Francisco
2026 Macroaxis LLC
COMMON DESTINATIONS
MAIN CATEGORIES
COMPANY